Amanote Research
Register
Sign In
Orphan and Ultra-Orphan Technologies: European and Australian Payer Perceptions
Value in Health
- United Kingdom
doi 10.1016/j.jval.2015.09.2027
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2015
Authors
S Hogue
AP Brogan
E Croft
Publisher
Elsevier BV
Related search
Psy60 - Orphan Versus Ultra-Orphan Drugs Prices in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php297 - Changes in Ultra-Orphan Drug Assessments in Poland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PHP46 Market Uptake of Orphan Drugs – A European Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Managed Entry Agreements and Orphan Drugs: A European Comparative Study (2006-2012)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Patient-Reported Outcome Claims in European and United States Orphan Drug Approvals
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy135 - Access to Orphan Drugs – Regulation Within the European Law
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Promoting Orphan Crops Research and Development
Planta
Genetics
Plant Science
The Effect of Resilience on the Psychological Well Being of Orphan and Non-Orphan Adolescents
Indian Journal of Mental Health
The Orphan Disease Networks
American Journal of Human Genetics
Genetics
